Company intelligence / Profile preview

BioXtreme

Petach Tikva, Israel
Ownership
Private
Employees
~10
Development stage
Other
01

Overview

BioXtreme is an Israeli rehabilitation robotics company developing neurorehabilitation devices for stroke and other neurological injuries. Its core approach is a patented Error Enhancement technology that uses robotic force application, adaptive algorithms, and virtual-reality-based therapy to accelerate motor recovery without relying primarily on cognitive compensation strategies. The company’s lead systems include deXtreme for upper-limb post-stroke rehabilitation and plaXtreme for palm and finger rehabilitation in patients with stroke, traumatic brain injury, and related neurological conditions. BioXtreme reports completed clinical studies for deXtreme, ongoing or recent clinical work for plaXtreme, and commercial/distribution activity in Europe, North America, and Southeast Asia. The business appears to operate as a private medtech company rather than a drug developer, with a focus on robotic neurotherapy systems for rehabilitation centers and hospitals.

Therapeutic areas
Neurology
Modalities
Device
Industry
Therapeutic Medical Devices
02

Partnerships

Advanced Medical SystemsAdvanced Medical Solutions s.r.o.RehabMartRobotimize GroupJamzoneVilla Beretta Rehabilitation Research Innovation InstituteHeliomare rehabilitation centreSTEPS Budapest Center for Robotic RehabilitationReuth Rehabilitation Hospital

Beyond the preview

Go deeper on BioXtreme.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioXtreme.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call